Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Business Wire
Links shared publicly online about this topic.
- 723total visits
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Business Wire
Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today announced the commercial U.S. launch of CYCLOSET® (bromocriptine mesyl
View full resource at businesswire.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Parkinson's Disease Medication, Drug, Parlodel
Most Recently Shared on November 16, 2010 at 1:57 pm By:
New diabetes drug enters market: Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET http://bit.ly/cjSjV4
Advertisement
